Q3 results: Rs 32.6 cr PAT, Re 1 interim dividend, Keva ME investment
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts more than Nifty Microcap 250 and 2.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
S H Kelkar Q3 FY26 consolidated revenue rose to Rs 583.80 cr from Rs 543.21 cr YoY. Q3 PAT at Rs 32.63 cr; 9M PAT swung to Rs 67.35 cr profit from Rs 28.43 cr loss, aided by Rs 35.92 cr net exceptional gain from Vashivali fire insurance recovery. 9M revenue at Rs 1,718.32 cr vs Rs 1,556.02 cr. Board declared Re 1 per share interim dividend (10%), record date Feb 13. Approved up to AED 5 million investment in Keva Middle East FZE. Unmodified auditor review.
Positive on dividend and insurance recovery; underlying PBT before exceptional items fell, so core business remains weak.